September is here – go lime

Today is the start of Lymphoma Awareness Month!

Today, 1st September, kicks off our annual Lymphoma Awareness Month and we invite you to go lime with us!

Every 2 hours an Australian is diagnosed with Lymphoma or CLL. Our goal is to
make sure no one faces lymphoma alone. Our nurses provide emotional,  practical and treatment support, as well as campaigning for better
cancer care. And because lymphoma affects more than just those facing
it, we are there for friends and
family too.

By
going lime this September (and into October) you will help to increase
awareness and help Australians face the lymphoma journey with hope and
courage. Not fear. 

Together we can make another Lymphoma Care Nurse a reality.

READ MORE

Share This

Contact Lymphoma Australia Today!

Please note: Lymphoma Australia staff are only able to reply to emails sent in English language.

For people living in Australia, we can offer a phone translation service. Have your nurse or English speaking relative call us to arrange this.

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.